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Background: Community-acquired pneumonia in children is common in China. To understand current clinical
characteristics and practice, we conducted a cross-sectional study to analyze quality of care on childhood pneumonia
in eight eastern cities in China.
Methods: Consecutive hospital records between January 1, 2010 and December 31, 2010 were collected from 13
traditional Chinese medicine (TCM) and western medicine (WM) hospitals in February, May, August, and November
(25 cases per season, 100 cases over the year), respectively. A predesigned case report form was used to extract data
from the hospital medical records.
Results: A total of 1298 cases were collected and analyzed. Symptoms and signs upon admission at TCM and WM
hospitals were cough (99.3% vs. 98.6%), rales (84.8% vs. 75.0%), phlegm (83.3% vs. 49.1%), and fever (74.9% vs. 84.0%)
in frequency. Patients admitted to WM hospitals had symptoms and signs for a longer period prior to admission than
patients admitted to TCM hospitals. Testing to identify etiologic agents was performed in 1140 cases (88.4%).
Intravenous antibiotics were administered in 99.3% (595/598) of cases in TCM hospitals and in 98.6% (699/700) of
cases in WM hospitals. Besides, Chinese herbal extract injection was used more frequently in TCM hospitals (491 cases,
82.1%) than in WM hospitals (212 cases, 30.3%) (p < 0.01). At discharge, 818 cases (63.0%) were clinically cured, with a
significant difference between the cure rates in TCM (87.6%) and WM hospitals (42.0%) (OR = 9.8, 95% confidence
interval (CI): 7.3 ~ 12.9, p < 0.01). Pathogen and previous medical history were more likely associated with the
disappearance of rales (OR = 7.2, 95% CI: 4.8 ~ 10.9). Adverse effects were not reported from the medical records.
Conclusions: Intravenous use of antibiotics is highly prevalent in children with community-acquired pneumonia
regardless of aetiology. There was difference between TCM and WM hospitals with regard to symptom profile and
the use of antibiotics. Intravenous use of herbal injection was higher in TCM hospitals than in WM hospitals. Most of
the cases were diagnosed based on clinical signs and symptoms without sufficient confirmation of aetiology. Audit of
current practice is urgently needed to improve care.
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Pneumonia is an inflammatory condition of the lung,
caused by different pathogens or other etiologic factors
[1]. Worldwide it is the leading cause of death in children
under five years old [2-4], with nearly 2 million deaths,
or almost 19.0% of total deaths in children [5]. In China, it
is estimated that there are an annual 21.1 million new
cases of pneumonia in children younger than 5 years of
age. This is a disease burden second only to India, which
has 43 million annual new cases in the same age group
[6,7]. In China, pneumonia accounts for most pediatric
hospitalizations [8].
Addressing childhood pneumonia remains a difficult
public health task in China. In terms of surveillance,
pneumonia is not even listed as a national notifiable
infectious disease [9], though in 2003 after the outbreak
of severe acute respiratory syndrome (SARS), “pneumonia
of unknown cause” was required to be reported because
airborne etiologic agents such as the SARS coronavirus
and human avian influenza virus (H5N1) are extremely
pathogenic and capable of quickly causing an epidemic
[10]. Moreover, China’s current health policy of “integra-
tion of TCM and Western medicine” need large-scale
surveys comparing cases of childhood pneumonia at TCM
and WM hospitals. Whether for guiding healthcare policy
or for improving disease management and prevention,
evaluating quality of care in paediatric pneumonia is of
paramount importance. Through the ages, WM hospitals
hold a principle status in public health. TCM hospitals
are gradually into mass vision, although at most time as
a complementary role. The two types of hospitals have
advantages and disadvantages. Commonly, WM hospitals
prefer to acute severe disease, and TCM hospitals prefer
to chronic mild disease. To exploring specific difference
on pneumonia therapy between two types of hospitals,
this cross-sectional study was designed to investigate
the distribution, diagnosis, treatment, and clinical outcome
of childhood community-acquired pneumonia in China.Methods
Study subjects
Data were drawn from 13 traditional Chinese medicine
(TCM) and western medicine (WM) hospitals in eight
eastern cities of China: Beijing, Dalian, Guangzhou, Jinan,
Nanjing, Shanghai, Shenyang, and Tianjin. Hospitals selec-
tion refers to region representation as provincial capitals
or coast cities, which reflects a better status of economic
and health in China. The hospitals are either affiliated
with universities or are provincial/municipal children’s
hospitals. Our protocol of study was approved by insti-
tutional review board (IRB) of the affiliated hospital of
Liaoning University of Traditional Chinese Medicine
(principle investigator) which covered each hospital’s IRB.Children between 1 and 14 years of age presenting to
the pediatric ward with clinical diagnosis of community-
acquired pneumonia were eligible for the study. Our
previous study [11-14] found that admission rates and
numbers of severe pneumonia cases, especially in
children <1 year of age, between TCM and WM hospitals
were highly incongruent. Therefore, to avoid bias in
the current study, we excluded children younger than one
year old and children with severe pneumonia. Indications
for severe pneumonia in patient age 0–3 years were
temperature >38.5°C, respiratory rate (RR) >70 breaths/min,
chest retractions, nasal flaring, cyanosis, intermittent apnea,
grunting, not feeding. Indications for severe pneumonia in
patient age 4–14 years were temperature >38.5°C, RR >50
breaths/min, nasal flaring, cyanosis, grunting, and signs of
dehydration.
Criteria of diagnosis were based on nationally-recognized
guidelines from either the Chinese Medical Association
[10] or Zhu Futang Textbook of Pediatrics [1], with
symptoms of fever, cough and dyspnea, fixed fine moist
rales, and patchy infiltrates on chest radiography. Criteria
for clinical therapeutic effectivness were also based on
national guidelines [15,16]. Clinical cure was defined as
temperature ≤37.2°C, disappearance of all symptoms except
occasional cough, and disappearance of rales. Clinical
improvement was defined as ≤37.2°C, all symptoms and
rales reduced. Failure was defined as no improvement
in presenting symptoms.
Data sampling was from January 1, 2010 to December
31, 2010. Total study sample was 1300. Consecutive
hospitalised records of children with paediatric pneumonia
were collected from each hospital in February, May,
August, and November, respectively, that is, first con-
secutive 25 cases each month, or 100 cases per hospital
over the 1-year study period.
Data collection
A predesigned case report form was applied by trained
investigators with clinical medicine backgrounds. Infor-
mation extracted were demographic data including name,
gender, age, hospital case number, birth history (route
of delivery, birth weight), past medical history (recurrent
respiratory tract diseases, eczema, asthma, allergic rhinitis,
and other allergies), duration of hospital stay, symptoms
and signs up to admission, diagnosis on admission and
at discharge, therapy modalities, and clinical outcome
at discharge. All records were input into an electronic
database based on EpiData software version 3.1.
Statistical analysis
EpiData software version 3.1 and IBM SPSS software
version 17.0 were used for record and data analyses. All
p values were applied with two-tailed tests and were not
adjusted for multiple testing. Logistic regression model
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types of hospitals and the improvement of symptoms.
Results
Clinical characteristics
A total of 1298 cases were collected from six TCM hos-
pitals and seven WM hospitals (Table 1). Data of two
cases were missing from one hospital. Male to female
ratio was 1.41:1. Previous medical history included re-
current pneumonia, recurrent bronchitis, and recurrent
upper respiratory tract infection (RURTI) in 349/1298
(26.9%) children; eczema in 130 (10.0%) children; asthma in
53 (4.1%) children; and allergic rhinitis in 56 (4.3%) chil-
dren. There was significant difference on previous medical
history in sampled patients between two types of hospitals.
Clinical manifestations on admission
Presentation of symptoms and signs on admission in
TCM hospitals were, from most to less frequent: cough
(99.3%), rales (84.8%), phlegm (83.3%), and fever (74.9%).
These percentages were nearly the same as those in WM
hospitals: cough (98.6%), fever (84%), rales (75.0%), and
phlegm (49.1%). Except for cough (p = 0.19), the frequen-
cies of rales, phlegm, and fever were significantly higher in
WM hospitals than in TCM hospitals (p < 0.01). Average
duration of illness from onset of symptoms and signs to
admission was markedly higher in WM hospitals than in
TCM hospitals (Table 2).Table 1 Characteristics of children hospitalised with pneumon
Characteristics TCM hospitals









Recurrent pneumoniaa 116 19.4




Allergic rhinitis 48 8.0
Abbreviations: TCM traditional Chinese medicine, WM Western medicine, RURTI recu
aRecurrent pneumonia is defined as at least two pneumonia episodes in a 1-year p
between each episode [17].
bRecurrent bronchitis is defined as in patients age 0–2 years, three or more bronch
cRURTI is defined as in patients age 0–2 years, seven or more episodes of URTI in 1
episodes of URTI in 1 year [10,17].
dIncludes cough-variant asthma.Aetiology diagnosis
Specific pathogens (one pathogen or more) were iden-
tified in 624 (48.1%) cases (Table 3). Negative patho-
gen findings were identified in 524 (40.4%) cases.
Eighty-five (6.5%) cases were not tested for pathogens.
Data were missing in 65 (5.0%) cases. TCM hospitals
performed significantly fewer pathogen tests as com-
pared to WM hospitals (30.3% versus 69.7%, p < 0.01).
In terms of pathogenic agent, Mycoplasma pneumoniae
(M pneumoniae) was identified more frequently, followed
by mixed pathogens.
Treatment
Prevalence of intravenous antibiotic use in TCM and
WM hospitals were 595 (99.3%) and 699 (98.6%), re-
spectively, in records of children with pneumonia, with
no significant difference (p = 0.34) (Table 4). However,
the patterns of antibiotic use in TCM and WM hospitals
were different. In TCM hospitals, antibiotics used were by
frequency, macrolides, third generation cephalosporins,
second generation cephalosporins, first generation cepha-
losporins, and β-lactamases. In WM hospitals, antibiotics
used were by frequency, third generation cephalospo-
rins, macrolides, second generation cephalosporins, β-
lactamases, and first generation cephalosporins. Oral
antibiotic use was significantly higher in WM hospitals
(243 cases) than in TCM hospitals (65 cases) (p < 0.01).
Chinese herbal injections were applied more frequentlyia in the sampled hospitals
WM hospitals χ2 P value








45 6.4 38.60 <0.01
13 1.9 5.59 0.02
54 7.7 17.33 <0.01
57 8.1 2.42 0.12
11 1.6 19.52 <0.01
8 1.1 30.75 <0.01
rrent upper respiratory tract infection, URTI upper respiratory tract infection.
eriod or at least three episodes over a lifetime, with normal chest radiography
itis episodes in 1 year; age 3–14 years, two or more episodes in 1 year [17].
year; age 3–5 years, six or more episodes in 1 year; 6–14 years, five or more
Table 2 Symptoms and signs of children with pneumonia on admission to hospital in the sampled hospitals
Frequency χ2 P Time from onset of symptoms
up to admission (days)
Z P
Symptoms TCM hospitals (n = 598) WM hospitals (n = 700) TCM hospitals WM hospitals
Cough 594 690 1.74 0.19 7.4 ± 6.6 8.8 ± 7.5 −6.11 <0.01
Rales 507 525 18.94 <0.01 1.2 ± 0.7 1.6 ± 1.7 −4.59 <0.01
Phlegma 498 344 164.89 <0.01 5.8 ± 9.7 4.0 ± 6.7 −5.87 <0.01
Feverb 448 588 16.52 <0.01 93.6 ± 64.2 147.1 ± 120.7 −8.91 <0.01
Tachypnea 196 87 78.31 <0.01 2.6 ± 2.9 4.9 ± 5.0 −4.72 <0.01
Dyspnea 24 70 17.21 <0.01 2.2 ± 2.3 7.0 ± 15.0 −3.47 <0.01
Abbreviations: TCM traditional Chinese medicine, WM Western medicine.
aIncludes white sputum, yellow sputum, or difficult to expectorate sputum.
bTime of onset of fever up to admission recorded in hours.
Wang et al. BMC Complementary and Alternative Medicine 2013, 13:367 Page 4 of 10
http://www.biomedcentral.com/1472-6882/13/367in TCM hospitals (491 cases, 82.1%) than in WM hospitals
(212 cases, 30.3%) (p < 0.01). Use of Chinese proprietary
medicines was similar across both types of hospitals (40.0%
in TCM hospitals versus 42.2% in WM hospitals) (p =
0.37). The most frequently used herbal injections in TCM
hospitals were Tanreqing, Danshen, Shengmai, and Xiyanp-
ing. While in WM hospitals they were Xiyanping and Xix-
innao. In addition, 312 (52.2%) children were treated
with herbal decoctions consisting of several herbs and
320 (53.5%) underwent external application of herbs.
Clinical outcome at discharge
Eight hundred and eighteen cases were identified as clinic-
ally cured when discharged, a cure rate of 63.0% (Tables 5
and 6). Relief rates of fever, though, were significantly
higher in TCM hospitals than in WM hospitals (OR = 3.5,
95% CI: 2.0 ~ 6.3, p < 0.01), but the time from onset of
fever to complete resolution was similar in two types of
hospitals (p = 0.013). Relief rates of cough and rales
were significantly higher in TCM hospitals than in WMTable 3 Etiologic agents identified in children hospitalised wi
Pathogen 1-3 years (N = 391) 4-7 ye
TCM hospitals WM hospitals TCM hospita
n % n % n %
Bacteriaa 1 0.7 32 15.6 4 1.2
M pneumoniaeb 37 22.8 36 17.6 89 27.
Virusc 0 0.0 25 12.2 4 1.2
Mixedd 0 0.0 41 20.0 5 1.5
Negative findinge 95 58.6 68 33.2 183 56.
Not testedf 29 17.9 3 1.4 42 12.
Total 162 205 327
Abbreviations: TCM traditional Chinese medicine, WM Western medicine.
aIdentified through sputum or blood culture.
bIdentified through serum antibody or antigen test.
cIdentified through nasopharyngeal secretion antibody test or serum antibody test.
dInfection of two or more pathogens.
eNone identified through above tests.
fNot go through any etiological tests.
gMissing 65 cases of etiological tests results.hospitals (OR = 2.6, 95% CI 2.6 ~ 3.2, OR = 4.1, 95% CI:
3.0 ~ 5.7, p < 0.01), but duration from onset to complete
relief of cough and rales was longer in TCM than in
WM hospitals (p < 0.01). Relief rates of phlegm were
significantly higher in WM hospitals than in TCM
hospitals (OR = 0.6, 95% CI 0.4 ~ 0.8, p < 0.01), and the
time from onset of phlegm to complete resolution was
longer in TCM than in WM hospitals (p < 0.01). There
was no difference in relief rates of tachypnea (OR = 1.2,
95%CI: 0.5 ~ 2.8, p = 0.66) between two types of hospitals.
The data of dyspnea did not match criteria of logistic
regression. The results were adjusted for gender, age,
pathogen and previous medical history listed in Table 1
and Table 3. Relief rates of rales were significantly
higher (OR = 7.2, 95% CI 4.8 ~ 10.9) after adjustification.
Duration of hospitalization was significantly longer in
WM hospitals than in TCM hospitals (p < 0.01). There
was marked difference in treatment efficacy between
TCM hospitals and WM hospitals (OR = 9.8, 95% CI
7.3 ~ 12.9, p < 0.01).th pneumonia in the sampled hospitals
ars (N = 673) 8-14 years (N = 234) Total
ls WM hospitals TCM hospitals WM hospitals
n % n % n %
37 11.6 1 0.9 7 6.2 82
2 59 18.6 39 36.1 39 34.5 299
23 7.2 0 0.0 4 3.6 56
101 31.8 1 0.9 39 34.5 187
0 96 30.2 58 53.7 24 21.2 524
8 2 0.6 9 8.4 0 0.0 85
318 108 113 1233g
Table 4 Treatment modalities in children hospitalised with pneumonia in the sampled hospitals
Medications TCM hospitals WM hospitals χ2 P value
Number (n = 598) % Number (n = 700) %
Antibiotics
IV 595 99.5 699 99.9 - 0.34
Macrolide 383 64.0 357 51.0 22.40 <0.01
Third generation cephalosporin 186 31.1 390 55.7 79.13 <0.01
Second generation cephalosporin 114 19.1 186 26.6 10.23 0.01
First generation cephalosporin 98 16.4 89 12.7 3.53 0.06
β-lactamase inhibitor 73 12.2 101 14.4 1.37 0.24
Oral 65 10.9 243 34.7 101.32 <0.01
Inhalationa 8a 1.3 0 0.0 - <0.01
Antiviral drugs
IV 10 1.7 77 11.0 44.87 <0.01
Inhalation 41 6.9 43 6.1 0.27 0.60
β2 agonist
Oral 205 34.3 216 30.9 1.73 0.19
Inhalation 342 57.2 205 29.3 102.99 <0.01
Steroids
IV 61 10.2 39 5.6 9.72 0.02
Inhalation 188 31.4 129 18.4 29.57 <0.01
TCM treatment
Chinese herbal extract injection 491 82.1 212 30.3 348.83 <0.01
Chinese patent drugs 239 40.0 297 42.2 0.81 0.37
Decoction 312 52.2 16 2.3 425.03 <0.01
External methods 320 53.5 179 25.6 106.39 <0.01
Abbreviations: TCM traditional Chinese medicine, WM Western medicine.
a7 cases of gentamicin and 1case of erythrocin.
Wang et al. BMC Complementary and Alternative Medicine 2013, 13:367 Page 5 of 10
http://www.biomedcentral.com/1472-6882/13/367Discussion
This cross-sectional study is the first of its kind investi-
gating the clinical profile of children hospitalized with
community-acquired pneumonia in China. Our sample
was drawn from children of different ages admitted with
pneumonia to 13 hospitals across eight eastern cities in
China. The consecutive hospital charts covered four
seasons. We believe the information gathered reflects
current clinical characteristics of childhood CAP in China.
Children with histories of respiratory disease or allergy
accounted for 41.0% of the 1298 cases. The percentage
(12.4%) of childhood pneumonia cases with histories of
recurrent pneumonia was high, similar to study findings
elsewhere [18,19]. Ozdemir and colleagues [20] in their
sample of 595 hospitalized children found that 62 (10.4%)
patients had histories of recurrent pneumonia. In our
study, 10.2% of admitted children had recurrent upper
respiratory tract infection (RURTI). Risk factors for RURTI
are known to be atopy (allergy), daycare attendance,
tobacco smoke or air pollution exposure, among others[21]. Such correlations for our sample need further
corroboration.
In our study, pneumonia patients with atopic condition
were common. Percentages of children with histories
of eczema, asthma, or allergic rhinitis were 10.0%, 4.1%,
and 4.3%, respectively. Bronchial pneumonia was a
complication of all asthma cases. There were also cases
of undiagnosed asthma among patients with recurrent
pneumonia. This seems to concur with other authors’
findings. For example, Ozdemir and colleagues [20] re-
ported that 30.6% of pneumonia inpatients had histor-
ies of asthma. Youn and Lee [22] found that history of
asthma might increase the risk of pneumonia caused by
Mycoplasma pneumoniae. Our study found that onset
of childhood pneumonia is closely associated with medical
history, in particular with respiratory or atopic conditions.
Therefore, attention should be focused on such children
and preventive measures applied such as immunization
[23,24] and educating families about avoiding contact
with allergens and other triggers.
Table 5 Symptom outcomes of children hospitalised with pneumonia in the sampled hospitals
TCM hospitals WM hospitals ORb 95% CIc Pd AORe 95% CIf APg
Fever
Cured 433 524
Failed 15 64 3.5 2.0 ~ 6.3 <0.01 3.7 2.0 ~ 6.8 <0.01
Cough
Cured 325 220
Failed 269 470 2.6 2.6 ~ 3.2 <0.01 2.5 2.0 ~ 3.1 <0.01
Phlegm
Cured 291 247
Failed 209 104 0.6 0.4 ~ 0.8 <0.01 0.4 0.2 ~ 0.6 <0.01
Tachypnea
Cured 179 78
Failed 17 9 1.2 0.5 ~ 2.8 0.7 1.7 0.5 ~ 6.0 0.4
Rales
Cured 446 335




Faileda 2 3 9.8 7.3 ~ 12.9 <0.01 9.7 7.3 ~ 13.1 <0.01
a5 cases experienced no improvement of symptoms and were voluntarily discharged.
bodds ratio.
codds ratio confidence interval.
dP value.
eThe odds ratio of adjusted gender, age, pathogen, previous medical history.
fThe odds ratio confidence interval of adjusted gender, age, pathogen, previous medical history.
gThe P value of adjusted gender, age, pathogen, previous medical history.
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hospitals in the presenting symptoms and signs at
admission. The World Health Organization’s (WHO)
guideline on the management of childhood pneumonia
[25] has been widely adopted in developing countries.
The guideline suggests that cough and dyspnea present
high sensitivity and specificity as main indicators forTable 6 Overall clinical outcome of children hospitalised with
Symptoms Outcome at dischargea







Duration of hospital stay - -
Abbreviations: TCM traditional Chinese medicine, WM Western medicine.
aSymptom almost disappeared.
bTime of onset of fever up to admission recorded in hours.
cIncludes white sputum, yellow sputum, or difficult to expectorate sputum.pediatric pneumonia diagnosis. However, in China dyspnea
is rarely applied to diagnose mild pediatric pneumonia
because though respiratory rate is increased, it is still
within normal range, especially in very young children.
Instead, cough and auscultatory findings are more com-
monly used. In our study, the prevalence of cough at
admission was similar between TCM hospitals andpneumonia in the sampled hospitals
χ2 P Time from admission to recovery
from symptoms (days)
Z P
TCM hospitals WM hospitals
0.23 0.63 53.2 ± 51.5 63.5 ± 63.0 −2.49 0.01
68.10 <0.01 9.5 ± 4.9 8.2 ± 3.5 −3.01 <0.01
13.30 <0.01 6.5 ± 9.1 3.1 ± 5.4 −7.55 <0.01
0.20 0.65 2.4 ± 2.0 3.4 ± 2.3 −4.67 <0.01
- 1.00 3.3 ± 2.2 3.8 ± 2.5 −0.68 0.50
105.92 <0.01 1.4 ± 1.6 1.7 ± 1.9 −9.07 <0.01
- - 8.7 ± 5.8 9.0 ± 3.8 −3.44 <0.01
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[25]. Although there was significant difference between
the two types of hospitals regarding other symptoms and
signs, a large proportion of children presented with fever
and rales.
Duration of symptoms and signs in children before
admission in WM hospitals was markedly longer than
in children in TCM hospitals. We suspect that the two
types of hospitals differ in regard to criteria for admis-
sion (such as severity of disease), ability of the family
to afford hospitalization, or bed availability. Further
studies are required to explore relevant factors that
influence hospital intake.
With the growing use of antibiotics in China, incidence
of childhood bacterial pneumonia stabilized and declined
between 1985 and 2008 [8]. But pneumonia caused by
other pathogens increased, especially respiratory syn-
cytial virus and mixed bacterial and viral infections. As
elsewhere in the world, China has seen a rise in pneumo-
nia caused by M pneumoniae in school-age children
[26,27]. Our study showed that M pneumoniae accounted
for 23.0% of all cases and was highest in preschool chil-
dren, who comprised 30.8% of all M pneumoniae cases.
Our previous randomised controlled trial [11] found that
M pneumoniae pneumonia showed highest prevalence
in preschool children, accounting for 43.6% of all cases.
Studies in some countries, such as Korea, also found
that M pneumoniae pneumonia was prevalent in 4 to
6 year-old children, reaching almost 60% [22,27,28].
Current evidence indicates that M pneumoniae pneu-
monia is appearing in increasingly younger children.
In our study, mixed pathogen infection was found in
14.4% of cases and was highest in preschool children at
22.0%. Some authors report that age is related closely to
pathogen type in mixed infections, with M pneumoniae
as one of the most common pathogens in such infec-
tions [29-31]. Our study found mixed infections with M
pneumoniae accounting for the highest proportion of
such infections of which the majority of cases were pre-
school children.
Pediatric pneumonia can be considered a syndrome
[32], thus comprehensive treatment and management
are needed [10,23]. In China, treatment of childhood
pneumonia involves myriad WM and TCM methods.
In both types of hospitals, common modalities include
intravenous injection of antibiotics and intravenous in-
jection of Chinese herbal preparations. External therapy
is also widely applied, mainly inhalation therapy in WM
hospitals and external application of herbal medicine and
cupping therapy in TCM hospitals.
Antibiotics were the mainstay of childhood pneumonia
treatment in the 13 hospitals included in our study.
Other authors [33-35] have reported that macrolides are
more effective in shortening disease duration and reducingseverity of M pneumoniae pneumonia compared with
other antibiotics. Macrolides are also more effective for
a wide range of bacterial pathogens [33,35], which might
be one of the reasons that in our study this class of
antibiotics was widely used. However, macrolide resist-
ance is a serious worldwide problem [36-38]. Suzuki and
colleagues [35] reported that of 96 cases of M pneumoniae
pneumonia in Yamagata, Japan, 83.0% were identified as
macrolide-resistant. Cephalosporins are widely used for
treating childhood pneumonia in China. In fact, there has
been inappropriate use and abuse of cephalosporins in
China [39,40], where cephalosporins use was higher than
Northern England (36% in 542 children [41]). In cases of
pneumonia caused by M pneumoniae, cephalosporins are
ineffective. In our study, among 1298 cases, 576 patients
(44.4%) received third generation cephalosporins and
300 patients (23.1%) received second generation cepha-
losporins. In general, selection of antibiotics in China has
not been based on drug sensitivity testing but on clinician
experience or medical insurance policy. With the promul-
gation by the Chinese Ministry of Health in August 2012
of regulations on the rational use of antibiotics [42], it
is hoped that arbitrary administration of antibiotics,
especially for childhood pneumonia, will be curbed.
In the modernization drive, TCM injection in China
was popularly used in both types of hospitals. There was
a lot of literatures [43-50] reported that the effect of
combined therapy with these injections plus conventional
treatment for pediatric pneumonia was better than
conventional treatment alone. Therefore, this could be
explained as the reasons for their use. However, the
adverse reaction must not to be overlooked as herb-drug
interaction might exist. According to literature review,
most common adverse reactions of Chinese herbal injec-
tions were rash and pruritus, diarrhea, or vomiting [51].
The high incidence of adverse reaction may be related to
physiological characteristics of children or irrational
use and preparing technology. Thus, appropriate measures
should be taken to reduce the occurrence of such events.
Length of hospitalization in our study was found to be
shorter in TCM hospitals than that in WM hospitals.
This may be related to the mildness of disease or turn-
over in ward beds as required by local health policy.
Another possible reason for shorter hospital stay in TCM
hospitals is that treatment that combines TCM and WM
based on syndrome differentiation is more effective than
WM alone in resolving symptoms, thus reducing disease
duration. In our study, fewer patients in TCM hospitals
than in WM hospitals were reported as having symptoms,
such as cough and sputum, at discharge. Shorter hospital
stay in TCM hospitals may also be attributed to lower
emphasis on strict adherence to discharge guidelines.
For example, patients deemed “cured” and who are
therefore discharged in TCM hospitals would in WM
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length of stay.
Treatment approach differs between TCM and WM.
TCM treatment is based on syndrome differentiation in
which individual signs and symptoms are evaluated and
treated together holistically instead of the solitary symp-
tom approach of WM. With pneumonia, TCM considers
sputum an essential sign as part of the overall syndrome.
Therefore, TCM clinicians focus on the presence of sputum
by observation of signs or airway suctioning. Treatment
is rendered based on the quantity, quality, and color of
sputum. WM clinicians, on the other hand, view these
finer points of sputum as less important, and assess
and treat based simply on whether or not sputum is
present. Indeed in our study, description of sputum
was lacking in most of the cases in WM hospitals.
TCM hospitals showed an advantage in relieving rales.
This may be because more external therapy, such as
herbal medicine application and cupping, was used in
TCM hospitals.
The disappearance of rales may be associated with
pathogen and previous medical history. Some pathogen
induced pneumonia such as M pneumoniae pneumonia
need more time to absorb inflammation, so rales usually
lasted longer than the others. Children with recurrent
respiratory disease were more susceptible to illness. Once
they got pneumonia, they need more time to recovery
than health children. Thus, we should pay more attention
to such children and prevent them from pneumonia.
Another difference between TCM and WM hospitals
in terms of treatment approach is aetiology diagnosis. As
mentioned, TCM practitioners render treatment based on
syndrome differentiation. As such, we suspect pathogen
testing plays a less important role in guiding treatment
than for WM practitioners. This may be the reason that in
our study, pathogen testing was ordered less frequently in
TCM hospitals than in WM hospitals. (National guidelines
in China recommend pathogen testing for CAP [1,10]).
Criteria for evaluating therapeutic effectiveness in child-
hood pneumonia between TCM and WM hospitals were
about the same. But weighting of individual parameters
was different. For example, based on guidelines [1,10],
fever normalization is foremost for assessing whether
pneumonia is only improved or cured. Improvement of
symptoms, such as cough, is used to evaluate the status
of disease (cured, clinical improvement, or failed). Clinical
cure of disease is based on the disappearance of rales
(moist rales) through auscultation.
A limitation of our study is that this was a cross-
sectional study. Our data was extracted from medical
records at 13 hospitals. Although we exercised quality
control to the best of our ability during the extraction
process, still the quality and scope of the study were
dependent on these records.Another limitation is that patients in this study were
drawn from eight cities in China. The data are not repre-
sentative of childhood CAP elsewhere in China, especially
non-urban areas where healthcare seeking behavior and
delivery practices vary widely from those in metropolitan
locales.
Conclusions
Our study presents the clinical characteristics of hospi-
talized children with pneumonia in eight eastern cities
in China. Intravenous use of antibiotics was highly
prevalent regardless of causative organism. As expected,
intravenous use of herbal injections was more prevalent in
TCM hospitals than in WM hospitals. This study finds
that the basic characteristics of children with pneumonia
admitted to the included TCM and WM hospitals are
similar. Universal issues, such as inconsistent application
of diagnostic criteria and treatment based on clinical
experience instead of current guidelines, exist in both
types of hospitals. Awareness of these and other short-
comings and taking necessary measures to overcome
will help clinicians in China improve their care practice
for children with pneumonia.
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